<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02952807</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT02952807</nct_id>
  </id_info>
  <brief_title>Vaginal Misoprostol and Foley Catheter for Induction of Labor</brief_title>
  <official_title>Sequential Versus Concurrent Use of Vaginal Misoprostol Plus Foley Catheter for Induction of Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      to compare between sequential and concurrent use of vaginal misopristol plus foleys catheter
      for induction of labor
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      two groups of patients who are eligible for labor induction were randomized to either
      sequential use of vaginal misopristol plus foleys catheter or concurrent use of vaginal
      misopristol plus foleys catheter.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>induction delivery interval (time from starting induction to delivery)</measure>
    <time_frame>48hours</time_frame>
    <description>safety issue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need of oxytocin for augmentation of labour</measure>
    <time_frame>48h</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of doses needed to bring on labour</measure>
    <time_frame>48h</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failed induction (failure to elicit contraction after 72 hours)</measure>
    <time_frame>72h</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperstimulation syndrome</measure>
    <time_frame>24h</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean section</measure>
    <time_frame>72h</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe neonatal morbidity or perinatal death</measure>
    <time_frame>28 days</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious maternal morbidity or maternal death</measure>
    <time_frame>42 days</time_frame>
    <description>safety issue</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Induction of Labor Affected Fetus / Newborn</condition>
  <arm_group>
    <arm_group_label>sequential</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sequential use of vaginal misoprotol Plus Foley Catheter for Induction of Labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Concurrent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Concurrent Use of Vaginal misoprostol Plus Foley Catheter for Induction of Labor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>vaginal Misoprostol Plus Foley Catheter</description>
    <arm_group_label>sequential</arm_group_label>
    <arm_group_label>Concurrent</arm_group_label>
    <other_name>cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley Catheter</intervention_name>
    <arm_group_label>sequential</arm_group_label>
    <arm_group_label>Concurrent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for labour induction Term pregnancy with alive fetus Bishop score less than
             five

        Exclusion Criteria:

          -  Age less than 18 years Previous uterine scar Nonvertex presentation Non-reassuring
             fetal status Fetal anomalies Fetal growth restriction Genital bleeding Tumors,
             malformations and/or ulcers of vulva, perineum or vagina
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ibrahim A el sharkwy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2016</study_first_submitted>
  <study_first_submitted_qc>November 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2016</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>IBRAHIM ABD ELGAFOR</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

